Intravitreal injection of Bevacizumab in diabetic macular edema
DOI:
https://doi.org/10.12669/pjms.306.5738Keywords:
Diabetic macular edema (DME), Vascular Endothelial Growth Factor (VEGF), Bevacizumab, Macular thickness.Abstract
Objective: To assess the effectiveness of intravitreal injection of Bevacizumab in the treatment of diabetic macular edema.
Methods: This case series was conducted at Department of Ophthalmology, Jinnah Post Graduate Medical Centre (JPMC), Karachi. The duration of study was six months from
Downloads
Additional Files
Published
2014-10-03
How to Cite
Ateeq Khan, A., Tahir, M. A., Miriam Cheema, A., Dahri, A., & Tareen, S. (2014). Intravitreal injection of Bevacizumab in diabetic macular edema. Pakistan Journal of Medical Sciences, 30(6). https://doi.org/10.12669/pjms.306.5738
Issue
Section
Original Articles
